EP 3253797 A1 20171213 - CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF
Title (en)
CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF
Title (de)
CHEMOKIN-IMMUNOGLOBULIN-FUSIONSPOLYPEPTIDE, ZUSAMMENSETZUNGEN DARAUS, VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON
Title (fr)
POLYPEPTIDES DE FUSION CHIMIOKINE-IMMUNOGLOBULINE, COMPOSITIONS, PROCÉDÉ DE FABRICATION ET UTILISATION ASSOCIÉS
Publication
Application
Priority
- US 201514612884 A 20150203
- US 2016016191 W 20160202
Abstract (en)
[origin: WO2016126719A1] This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/395 (2006.01)
CPC (source: EP)
C07K 14/521 (2013.01); C07K 2319/30 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016126719 A1 20160811; CN 107207603 A 20170926; EP 3253797 A1 20171213; EP 3253797 A4 20181003
DOCDB simple family (application)
US 2016016191 W 20160202; CN 201680007087 A 20160202; EP 16747125 A 20160202